BridgeMD
Perioperative oral analgesia versus intravenous analgesia for knee arthroscopy, a randomized, double-blinded, non-inferiority trial. OVIKA-trial - S68618
EU CTIS ID: 2024-510789-17-00
What this study is testing
Evaluating the analgesic effect of oral versus intravenous analgesics postoperative
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Minor knee surgery under general anaesthesia, including arthroscopic meniscectomy and synovectomy, diagnostic arthroscopy, meniscus repair and arthroscopic lavage.
- >=18 years of age
- ASA 1-3 suitable for ambulatory surgery
- >= 50 kg
- Voluntary written informed consent of the participant
- Dutch speaking
You likely can't join if
- History of liver diseases, renal insufficiency, epilepsy, allergy to paracetamol or ibuprofen
- Any disorder which, in the Investigator's opinion, might jeopardize the participant's safety or compliance with the protocol
- Any prior or concomitant treatment(s) that might jeopardize the participant's safety or that would compromise the integrity of the Trial.
- Participation in an interventional Trial with an investigational medicinal product (IMP) or device.
- A contraindication for the use of paracetamol or ibuprofen
- Non-compliance of the patient
See the full eligibility criteria
- Minor knee surgery under general anaesthesia, including arthroscopic meniscectomy and synovectomy, diagnostic arthroscopy, meniscus repair and arthroscopic lavage.
- >=18 years of age
- ASA 1-3 suitable for ambulatory surgery
- >= 50 kg
- Voluntary written informed consent of the participant
- Dutch speaking
- History of liver diseases, renal insufficiency, epilepsy, allergy to paracetamol or ibuprofen
- Any disorder which, in the Investigator's opinion, might jeopardize the participant's safety or compliance with the protocol
- Any prior or concomitant treatment(s) that might jeopardize the participant's safety or that would compromise the integrity of the Trial.
- Participation in an interventional Trial with an investigational medicinal product (IMP) or device.
- A contraindication for the use of paracetamol or ibuprofen
- Non-compliance of the patient
- postive urine pregnancy test in women of childbearing potential
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.